Metals in neurodegeneration: Involvement of oxidants and oxidant-sensitive transcription factors

Molecular Aspects of Medicine

Volumn 25, Issue 1-2, 2004, Pages 103-115

  Oteiza, Patricia I ^a,b   Mackenzie, Gerardo G ^a,b   Verstraeten, Sandra V ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Al, aluminum; IP3, inositol triphosphate; O2 , superoxide anion; Pb, lead; PI PLC, phosphatidylinositol specific phospholipase C; PIP2, phosphatidylinositol biphosphate; PKC, protein kinase C; Zn, zinc

Indexed keywords

ALUMINUM; LEAD; OXIDIZING AGENT; TRANSCRIPTION FACTOR; ZINC;

APOPTOSIS; BLOOD RHEOLOGY; BRAIN MEMBRANE; BRAIN NERVE CELL; CALCIUM SIGNALING; CONCENTRATION (PARAMETERS); HUMAN; LEAD POISONING; METAL BINDING; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; REVIEW; SIGNAL TRANSDUCTION; ZINC DEFICIENCY;

ALUMINUM; ANIMALS; HUMANS; LEAD; METALS; NEURODEGENERATIVE DISEASES; OXIDANTS; TRANSCRIPTION FACTORS; ZINC;

EID: 1642422753     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mam.2004.02.012     Document Type: Review

References (62)

1. Adonaylo V.N., Oteiza P.I. Lead intoxication: antioxidant defenses and oxidative damage in rat brain. Toxicology. 135:1999;77-85.
2. 2+ promotes lipid oxidation and alterations in membrane physical properties. Toxicology. 132:1999;19-32.
3. Bray T.M., Bettger W.J. The physiological role of zinc as an antioxidant. Free Radic. Biol. Med. 8:1990;281-291.
4. 2+ inhibits alpha-ketoglutarate- stimulated mitochondrial respiration and the isolated alpha-ketoglutarate dehydrogenase complex. J. Biol. Chem. 275:2000;13441-13447.
5. Campbell A., Yang E.Y., Tsai-Turton M., Bondy S.C. Pro-inflammatory effects of aluminum in human glioblastoma cells. Brain Res. 93:2002;60-65.
6. Chakraborti T., Kim K.A., Goldstein G.G., Bressler J.P. Increased AP-1 DNA binding activity in PC12 cells treated with lead. J. Neurochem. 73:1999;187-194.
7. Choi D.W., Koh J.Y. Zinc and brain injury. Annu. Rev. Neurosci. 21:1998;347-375.
8. Christen Y. Oxidative stress and Alzheimer disease. Am. J. Clin. Nutr. 71:2000;621S-629S.
9. Dineley K.E., Votyakova T.V., Reynolds I.J. Zinc inhibition of cellular energy production: implications for mitochondria and neurodegeneration. J. Neurochem. 85:2003;563-570.
10. Edwardson J. Aluminum in Chemistry, Biology and Medicine. 1991;Raven Press, New York.
11. Flaten T.P. Aluminium as a risk factor in Alzheimer's disease, with emphasis on drinking water. Brain Res. Bull. 55:2001;187-196.
12. Frederickson C.J. Neurobiology of zinc and zinc-containing neurons. Int. Rev. Neurobiol. 31:1989;145-238.
13. Ganrot P.O. Metabolism and possible health effects of aluminum. Environ. Health Perspect. 65:1986;363-441.
14. Ghribi O., Herman M.M., DeWitt D.A., Forbes M.S., Savory J. Abeta(1-42) and aluminum induce stress in the endoplasmic reticulum in rabbit hippocampus, involving nuclear translocation of gadd 153 and NF-kappaB. Brain Res. Mol. Brain Res. 96:2001;30-38.
15. Golub M.S., Han B., Keen C.L. Aluminum uptake and effects on transferrin mediated iron uptake in primary cultures of rat neurons, astrocytes and oligodendrocytes. Neurotoxicology. 20:1999;961-970.
16. Golub M.S., Keen C.L., Gershwin M.E. Moderate zinc-iron deprivation influences behavior but not growth in adolescent rhesus monkeys. J. Nutr. 130:2000;354S-357S.
17. Hossain M.A., Bouton C.M., Pevsner J., Laterra J. Induction of vascular endothelial growth factor in human astrocytes by lead. Involvement of a protein kinase C/activator protein-1 complex-dependent and hypoxia-inducible factor 1-independent signaling pathway. J. Biol. Chem. 275:2000;27874-27882.
18. Huijbregts R.P.H., Topalof L., Bankaitis V.A. Lipid metabolism and regulation of membrane trafficking. Traffic. 1:2000;195-202.
19. Johnson V.J., Sharma R.P. Aluminum disrupts the pro-inflammatory cytokine/neurotrophin balance in primary brain rotation-mediated aggregate cultures: possible role in neurodegeneration. Neurotoxicology. 24:2003;261-268.
20. Koh J.Y., Suh S.W., Gwag B.J., He Y.Y., Hsu C.Y., Choi D.W. The role of zinc in selective neuronal death after transient global cerebral ischemia. Science. 272:1996;1013-1016.
21. Kong S., Liochev S., Fridovich I. Aluminum(III) facilitates the oxidation of NADH by the superoxide anion. Free Radic. Biol. Med. 13:1992;79-81.
22. 2+ ions with glyceraldehyde-3-phosphate dehydrogenase from bovine heart and rabbit muscle. Int. J. Biochem. 24:1992;1501-1505.
23. Lassing I., Lindberg U. Specific interaction between phosphatidylinositol 4,5-bisphosphate and profilactin. Nature. 314:1985;472-474.
24. Lezoualc'h F., Sagara Y., Holsboer F., Behl C. High constitutive NF-kappaB activity mediates resistance to oxidative stress in neuronal cells. J. Neurosci. 18:1998;3224-3232.
25. Lidsky T.I., Schneider J.S. Lead neurotoxicity in children: basic mechanisms and clinical correlates. Brain. 126:2003;5-19.
26. Lieb K., Fiebich B.L., Schaller H., Berger M., Bauer J. Interleukin-1 beta and tumor necrosis factor-alpha induce expression of alpha 1-antichymotrypsin in human astrocytoma cells by activation of nuclear factor-kappa B. J. Neurochem. 67:1996;2039-2044.
27. Lione A. Aluminum toxicology and the aluminum-containing medications. Pharmacol. Ther. 29:1985;255-285.
28. Loikkanen J.J., Naarala J., Savolainen K.M. Modification of glutamate-induced oxidative stress by lead: the role of extracellular calcium. Free Radic. Biol. Med. 24:1998;377-384.
29. 2+ with the bovine-heart mitochondrial bc1 complex. Eur. J. Biochem. 197:1991;555-561.
30. Mackenzie G.G., Keen C.L., Oteiza P.I. Zinc status of human IMR-32 neuroblastoma cells influences their susceptibility to iron-induced oxidative stress. Dev. Neurosci. 24:2002;125-133.
31. Mackenzie G.G., Zago M.P., Keen C.L., Oteiza P.I. Low intracellular zinc impairs the translocation of activated NF-kB to the nuclei in human neuroblastoma IMR-32 cells. J. Biol. Chem. 277:2002;34610-34617.
32. Marchetti C. Molecular targets of lead in brain neurotoxicity. Neurotox. Res. 5:2003;221-236.
33. McDermott J.R., Smith A.I., Iqbal K., Wisniewski H.M. Brain aluminum in aging and Alzheimer disease. Neurology. 29:1979;809-814.
34. Meglio L., Oteiza P.I. Aluminum enhances melanin-induced lipid peroxidation. Neurochem. Res. 24:1999;1001-1008.
35. Naarala J.T., Loikkanen J.J., Ruotsalainen M.H., Savolainen K.M. Lead amplifies glutamate-induced oxidative stress. Free Radic. Biol. Med. 19:1995;689-693.
36. Nostrandt A.C., Shafer T.J., Mundy W.R., Padilla S. Inhibition of rat brain phosphatidylinositol-specific phospholipase C by aluminum: regional differences, interactions with aluminum salts, and mechanisms. Toxicol. Appl. Pharmacol. 136:1996;118-125.
37. Oteiza P.I., Olin K.L., Fraga C.G., Keen C.L. Zinc deficiency causes oxidative damage to proteins, lipids and DNA in rat testes. J. Nutr. 125:1995;823-829.
38. Oteiza P.I., Adonaylo V.N., Keen C.L. Cadmium-induced testes oxidative damage in rats can be influenced by dietary zinc intake. Toxicology. 137:1999;13-22.
39. Oteiza P.I., Clegg M.S., Zago M.P., Keen C.L. Zinc deficiency induces oxidative stress and AP-1 activation in 3T3 cells. Free Radic. Biol. Med. 28:2000;1091-1099.
40. Palmiter R.D., Findley S.D. Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc. EMBO J. 14:1995;639-649.
41. Pennington J.A. Aluminium content of foods and diets. Food Addit. Contam. 5:1988;161-232.
42. Pratico D., Uryu K., Sung S., Tang S., Trojanowski J.Q., Lee V.M. Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice. Faseb J. 16:2002;1138-1140.
43. Ramesh G.T., Manna S.K., Aggarwal B.B., Jadhav A.L. Lead activates nuclear transcription factor-kappaB, activator protein-1, and amino-terminal c-Jun kinase in pheochromocytoma cells. Toxicol. Appl. Pharmacol. 155:1999;280-286.
44. Ramesh G.T., Manna S.K., Aggarwal B.B., Jadhav A.L. Lead exposure activates nuclear factor kappa B, activator protein-1, c-Jun N-terminal kinase and caspases in the rat brain. Toxicol. Lett. 123:2001;195-207.
45. Roberts E. Alzheimer's disease may begin in the nose and may be caused by aluminosilicates. Neurobiol. Aging. 7:1986;561-567.
46. Savory J., Herman M.M., Ghribi O. Intracellular mechanisms underlying aluminum-induced apoptosis in rabbit brain. J. Inorg. Biochem. 97:2003;151-154.
47. Sciorra V.A., Rudge S.A., Prestwich G.D., Frohman M.A., Engebrect J., Morris A.J. Identification of a phosphoinositide binding motif that mediates activation of mammalian and yeast phospholipase D isoenzymes. EMBO J. 18:1999;5911-5921.
48. 2+-permeable AMPA/kainate channels triggers prolonged mitochondrial superoxide production. Proc. Natl. Acad. Sci. USA. 96:1999;2414-2419.
49. Shafer T.J., Mundy W.R. Effects of aluminum on neuronal signal transduction: mechanisms underlying disruption of phosphoinositide hydrolysis. Gen. Pharmac. 26:1995;889-895.
50. Shafer T.J., Mundy W.R., Wilson H.A. Aluminum decreases muscarinic, adrenergic, and metabotropic receptor-stimulated phosphoinositide hydrolysis in hippocampal and cortical slices from rat brain. Brain Res. 629:1993;133-140.
51. + and inhibition of glycolysis. J. Neurosci. 20:2000;3139-3146.
52. Shimizu H., Mori T., Koyama M., Sekiya M., Ooami H. A correlative study of the aluminum content and aging changes of the brain in non-demented elderly subjects. Nippon Ronen Igakkai Zasshi. 31:1994;950-960.
53. Verstraeten S.V., Nogueira L.V., Schreier S., Oteiza P.I. Effect of trivalent metal ions on phase separation and membrane lipid packing: role in lipid peroxidation. Arch. Biochem. Biophys. 338:1997;121-127.
54. 2+-initiated lipid peroxidation. Arch. Biochem. Biophys. 322:1995;284-290.
55. 3+ and related metals on membrane phase state and hydration: correlation with lipid oxidation. Arch. Biochem. Biophys. 375:2000;340-346.
56. 3+-mediated changes in membrane physical properties participate in the inhibition of polyphosphoinositide hydrolysis. Arch. Biochem. Biophys. 408:2002;263-271.
57. Villeda-Hernandez J., Barroso-Moguel R., Mendez-Armenta M., Nava-Ruiz C., Huerta-Romero R., Rios C. Enhanced brain regional lipid peroxidation in developing rats exposed to low level lead acetate. Brain. Res. Bull. 55:2001;247-251.
58. Ward N., Mason J. Neutron activation analysis techniques for identifying elemental status in Alzheimer's disease. J. Radioanal. Nucl. Chem. 113:1987;515-526.
59. White R.F., Diamond R., Proctor S., Morey C., Hu H. Residual cognitive deficits 50 years after lead poisoning during childhood. Br. J. Ind. Med. 50:1993;613-622.
60. Yasui M., Kihira T., Ota K., Mukoyama M., Adachi K. Aluminum deposition in the central nervous system tissues of patients with Parkinson's disease. Rinsho Shinkeigaku. 31:1991;1095-1098.
61. Yokel R., Rhineheimer S., Brauer R., Sharma P., Elmore D., McNamara P. Brain aluminum clearance is slow. Toxicol. Sci. 54:2000;35.
62. 26Al exposure. Toxicol. Sci. 64:2001;77-82.